Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02445248
Title Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients (JULIET)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

diffuse large B-cell lymphoma

Therapies

Tisagenlecleucel

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | DEU | CAN | AUT


No variant requirements are available.